Single-Atom Engineering of a Sonosensitizer to Enable Mitochondrial Sabotage for Potent STING-Mediated Antitumor Immunity
Nano Letters · 03.11.2026
DOI: 10.1021/acs.nanolett.6c02984 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, online erschienen am 03.11.2026. Verfasst von Siqi Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of High Performance Polymer Materials and Technology, State Key Laboratory of Analytical Chemistry for Life Science, The Comprehen…. Hauptthemen laut MEDLINE: Mitochondria, Membrane Proteins. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, State Key Laboratory of Analytical Chemistry for Life Science, National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
While sonodynamic therapy (SDT) holds promise for localized tumor ablation, its ability to elicit systemic antitumor immunity remains inadequate due to weak immunogenic priming. Herein, we report a dual-engine single-atom-engineered nanoplatform (MNSe) that converts SDT into a robust immunological reprogrammer via irreversible mitochondrial sabotage. By tuning the central heteroatom of an isoindigo derivative, selenium substitution significantly amplifies spin–orbit coupling, maximizing ultrasound-triggered reactive oxygen species (ROS) generation. Conjugation with a triphenylphosphonium moiety precisely localizes this amplified oxidative stress to mitochondria. Rationally coupling atom-enhanced ROS with precise subcellular targeting effectively exceeds the biological damage threshold and overcomes endogenous repair mechanisms. The resulting organelle disruption triggers substantial cytosolic leakage of mitochondrial DNA to robustly activate the cGAS-STING pathway. In vivo, this drives interferon-β secretion and CD8+ T-cell infiltration to inhibit primary and distant tumors and to establish durable immunological memory against tumor recurrence, providing a powerful paradigm for spatiotemporally controllable cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of High Performance Polymer Materials and Technology, State Key Laboratory of Analytical Chemistry for Life Science, The Comprehensive Cancer Centre, Nanjing Drum Tower Hospital, School of Chemistry,…
- School of Biomedical Science and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou511442, P. R. China.
- State Key Laboratory of Flexible Electronics and Institute of Advanced Materials, Nanjing University of Posts and Telecommunications, Nanjing210023, P. R. China.
- Chemistry and Biomedicine Innovation Center, ChemBioMed Interdisciplinary Research Center at Nanjing University, Nanjing University, Nanjing210023, P. R. China.
ORCID-Profile: Shidang Xu, Wei Wu, Xiqun Jiang, Xu Zhen
Förderung
- Natural Science Foundation of Jiangsu Province
- State Key Laboratory of Analytical Chemistry for Life Science
- National Natural Science Foundation of China (NSFC)
- Jiangsu Provincial Science and Technology Major Project on Innovative Biopharmaceutical
- the High Performance Computing Center, Nanjing University
Zitieren
APA
Li, S., Li, C., Wu, M., Li, H., Zhou, W., Tan, W., Xu, S., Sun, B., Li, R., Wu, W., Jiang, X., & Zhen, X. (2026). Single-Atom Engineering of a Sonosensitizer to Enable Mitochondrial Sabotage for Potent STING-Mediated Antitumor Immunity. Nano Letters. https://doi.org/10.1021/acs.nanolett.6c02984
Vancouver
Li S, Li C, Wu M, Li H, Zhou W, Tan W, et al. Single-Atom Engineering of a Sonosensitizer to Enable Mitochondrial Sabotage for Potent STING-Mediated Antitumor Immunity. Nano Letters. 2026. doi:10.1021/acs.nanolett.6c02984
BibTeX
@article{Li2026,
author = {Li, Siqi and Li, Chenchen and Wu, Min and Li, Haoze and Zhou, Wenya and Tan, Wenhao and Xu, Shidang and Sun, Bo and Li, Rutian and Wu, Wei and Jiang, Xiqun and Zhen, Xu},
title = {Single-Atom Engineering of a Sonosensitizer to Enable Mitochondrial Sabotage for Potent STING-Mediated Antitumor Immunity},
journal = {Nano Letters},
year = {2026},
doi = {10.1021/acs.nanolett.6c02984}
}
EUVIMED